When it comes to product development, the management of third-party intellectual property (IP) to ensure freedom to operate is of paramount importance. Drug development is no different. Imagine ...
Emcure partners with Roche to enhance access to nephrology and transplant therapies for chronic kidney disease in India.
Credit: Getty Images. Vadadustat is an oral hypoxia-inducible factor prolyl hydroxylase inhibitor. Vadadustat was found to be noninferior to a long-acting erythropoiesis-stimulating agent (ESA) for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results